Literature DB >> 1628199

White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.

P Scheltens1, F Barkhof, J Valk, P R Algra, R G van der Hoop, J Nauta, E C Wolters.   

Abstract

In a prospective magnetic resonance imaging (MRI) study we evaluated the prevalence and severity of white matter changes in 29 patients with Alzheimer's Disease (AD) and 24 age-matched healthy elderly, all without cerebrovascular risk factors. The AD patients were divided into two groups according to age at onset of symptoms, one with presenile onset AD (n = 13) and one with senile onset AD (n = 16), who were matched for dementia severity. Signal hyperintensities were rated using a semiquantitative scoring method, separately in the periventricular region (PVH) and in the lobar white matter (WMH), as well as in the basal ganglia (BGH) and in the infratentorial region (ITFH). Cortical atrophy as a parameter of grey matter involvement was rated on a 0 (absent) to 3 (severe) scale. We found PVH, WMH and BGH scores to be significantly higher in senile onset AD patients than in age-matched controls. By means of multiple linear logistic regression we found that PVH, WMH and BGH scores were significantly dependent on the diagnosis of senile onset AD, while the PVH score also showed a significant age dependency. Cortical atrophy did not differ significantly between presenile onset AD and senile onset AD patients. These results indicate that presenile onset AD and senile onset AD patients differ with respect to white matter involvement, but not with respect to grey matter involvement on MRI. Since cerebrovascular risk factors were excluded these findings may indicate that senile onset AD patients display more small vessel involvement (arteriolosclerosis) than presenile onset AD patients, suggesting additional (microvascular) factors for the dementia syndrome in senile onset AD. Our data lend support to the growing body of evidence that AD is heterogeneous, consisting of at least two types. Based on our findings two forms can be distinguished: (i) a 'pure' form of the disease, usually with early disease onset, and no more white matter changes than normal for age; (ii) a 'mixed' form, usually with disease onset later in life, and showing more white matter changes on MRI than normal for age.

Entities:  

Mesh:

Year:  1992        PMID: 1628199     DOI: 10.1093/brain/115.3.735

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  63 in total

1.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.

Authors:  R Barber; P Scheltens; A Gholkar; C Ballard; I McKeith; P Ince; R Perry; J O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease.

Authors:  S E Starkstein; L Sabe; S Vázquez; G Di Lorenzo; A Martínez; G Petracca; A Tesón; E Chemerinski; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

3.  Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.

Authors:  V Jelic; P Julin; M Shigeta; A Nordberg; L Lannfelt; B Winblad; L O Wahlund
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

4.  Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.

Authors:  J Tian; J Shi; K Bailey; C L Lendon; S M Pickering-Brown; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

5.  Diagnostic utility of cerebral white matter integrity in early Alzheimer's disease.

Authors:  David K Johnson; Willis Barrow; Raeann Anderson; Amith Harsha; Robyn Honea; William M Brooks; Jeffrey M Burns
Journal:  Int J Neurosci       Date:  2010-08       Impact factor: 2.292

6.  White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy.

Authors:  P Vermersch; J Roche; M Hamon; C Daems-Monpeurt; J P Pruvo; P Dewailly; H Petit
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

7.  The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition.

Authors:  J He; V S S Wong; E Fletcher; P Maillard; D Y Lee; A-M Iosif; B Singh; O Martinez; A E Roach; S N Lockhart; L Beckett; D Mungas; S T Farias; O Carmichael; C DeCarli
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

8.  An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases.

Authors:  Pauline Maillard; Nicolas Delcroix; Fabrice Crivello; Carole Dufouil; Sebastien Gicquel; Marc Joliot; Nathalie Tzourio-Mazoyer; Annick Alpérovitch; Christophe Tzourio; Bernard Mazoyer
Journal:  Neuroradiology       Date:  2007-10-16       Impact factor: 2.804

9.  Factors affecting the age of onset and rate of progression of Alzheimer's disease.

Authors:  J V Bowler; D G Munoz; H Merskey; V Hachinski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 10.  Magnetic resonance imaging in degenerative ataxic disorders.

Authors:  I E Ormerod; A E Harding; D H Miller; G Johnson; D MacManus; E P du Boulay; B E Kendall; I F Moseley; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.